Clinical Trial

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective study to evaluate in-field disease control, survival and late toxicity in patients with cervical cancer or pelvic recurrence treated with spatially fractionated RT. The study will include patients with primary cervical cancer or pelvic recurrence not suitable for brachytherapy in view of anticipated or actual suboptimal target coverage due to aberrant anatomy or large residual disease at the time of brachytherapy.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-10-14; most recent amendment 2026-02-18.
Status change: Active, Not Recruiting → Recruiting 2026-02-18
Status change: Recruiting → Active, Not Recruiting 2026-02-03
Status change: Active, Not Recruiting → Recruiting 2026-01-03
Status change: Recruiting → Active, Not Recruiting 2025-09-20
Status change: Not Yet Recruiting → Recruiting 2025-08-18
Trial Details
NCT Number NCT06644846
Lead Sponsor Tata Memorial Hospital
Conditions Cervical Cancer, Gynecologic Cancer, Recurrent Cancer
Enrollment 20 participants
Start Date 2024-10-04
Primary Completion 2027-02-28 (estimated)
Study Completion 2029-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-02-20